HGF and MET mutations in primary and secondary lymphedema - Wikidata - awgldk - TriplyDB

HGF and MET mutations in primary and secondary lymphedema

HGF and MET mutations in primary and secondary lymphedema

http://www.wikidata.org/entity/Q34983851

about

GJC2 missense mutations cause human lymphedema Recent progress in the treatment and prevention of cancer-related lymphedema Vascular anomalies: from genetics toward models for therapeutic trials Evidence for SH2 domain-containing 5'-inositol phosphatase-2 (SHIP2) contributing to a lymphatic dysfunction Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema.Genetics of lymphatic anomalies Assessment of lymphatic contractile function after manual lymphatic drainage using near-infrared fluorescence imaging.Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update Human Lymphatic Architecture and Dynamic Transport Imaged Using Near-infrared Fluorescence.Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery.Bridging the divide between pathogenesis and detection in lymphedema.Limb Differences in the Therapeutic Effects of Complex Decongestive Therapy on Edema, Quality of Life, and Satisfaction in Lymphedema Patients.Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging.A randomized controlled trial comparing two types of pneumatic compression for breast cancer-related lymphedema treatment in the home.Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment Adrenomedullin haploinsufficiency predisposes to secondary lymphedema.From germline towards somatic mutations in the pathophysiology of vascular anomalies.The role of gap junctions in inflammatory and neoplastic disorders (Review).Potassium Channel Candidate Genes Predict the Development of Secondary Lymphedema Following Breast Cancer Surgery.GJA4/Connexin 37 Mutations Correlate with Secondary Lymphedema Following Surgery in Breast Cancer Patients.

P2860

Q21710710-A620EE37-3686-4987-B716-54592E4053E2 Q27009895-2A47586D-500C-4381-9837-A1F4FFD7EE55 Q27025402-A7E9E4C8-19C3-41A8-AB8D-3422C8522DB8 Q27329602-24785E48-FB28-4E8C-9799-9B0EA0D232AD Q27334274-97AE9DFE-0222-4190-909F-7A410DA91D21 Q28308201-4554FD9D-7EB9-4308-AD24-DF806ABC7275 Q30500883-66047C9F-F738-44A2-8348-6C4CC99C9E93 Q30524322-86D7BA9E-C13D-4A9C-895B-078F2A14A90B Q34398305-654D4CF4-A3D4-44F3-BB74-750413543AD8 Q34683635-1C52C4A1-16D5-438A-9B5A-4AE51F9B4CA0 Q35566114-FF908BC8-C392-4962-A8CA-12EAFCD0E126 Q35833505-87487049-404E-4E15-AC7A-6E25D5055A13 Q35942344-27792C0D-9CBD-45C8-B3F2-368912DD06DB Q36345481-8512908D-62BD-4CFD-B19E-CFF4365BE5C6 Q36763693-EA9E67DF-7C53-4D41-AFAB-08523C805561 Q36928498-2D32A151-C45A-45A0-9CAC-B23DDECF39F9 Q37134125-0DD7B634-E5C2-4E62-803B-CB06831C4BD3 Q39093592-30C6DA44-DA1F-4F25-9A6E-8E83F769DCDF Q46796586-EBF6C5F8-E356-4688-952A-A2309D4EC796 Q52374818-D9097AE8-6741-44E3-9413-9BFBEE9773B5

P2860

HGF and MET mutations in primary and secondary lymphedema

http://www.wikidata.org/entity/Q34983851

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

HGF and MET mutations in primary and secondary lymphedema

@ast

HGF and MET mutations in primary and secondary lymphedema

@en

HGF and MET mutations in primary and secondary lymphedema

@nl

type

label

HGF and MET mutations in primary and secondary lymphedema

@ast

HGF and MET mutations in primary and secondary lymphedema

@en

HGF and MET mutations in primary and secondary lymphedema

@nl

prefLabel

HGF and MET mutations in primary and secondary lymphedema

@ast

HGF and MET mutations in primary and secondary lymphedema

@en

HGF and MET mutations in primary and secondary lymphedema

@nl

P1433

Q34983851-F3FB5C17-0C87-4D86-ADB9-0AE1F2343181

P1476

Q34983851-FB7D2E7D-2E99-479A-91D7-67086AAC1633

P2093

Q34983851-0851B1CE-A36C-4E97-9001-CDF7BFF5E329

Q34983851-0AE991B8-8DC7-41DD-ACB0-0D56D81738B6

Q34983851-34847BF6-2FA8-4142-866C-FD58B629C536

Q34983851-44275CA5-4274-4850-8FBA-03530257A4CD

Q34983851-63DBD35C-9327-49D4-B04D-6B29EC779999

Q34983851-81E739FF-B190-4E48-9019-C18A54923498

Q34983851-DEF61676-7136-4FEB-B728-D23FD6B785A0

Q34983851-E3E5CDFB-D3EF-45FB-8C70-2779C92B67B5

P2860

Q34983851-0641FD20-FD4E-4B4C-AA41-B402839E95BC

Q34983851-0FB390BE-1CBF-471C-99E3-0738FE1C152C

Q34983851-17C2CE9E-804A-49E1-8A5D-9EAA8E72A4FE

Q34983851-1EABF98A-75C4-481F-A368-A4B91785C1E6

Q34983851-2A7B0BA8-0E6C-4D3E-BA70-2A0717F5F5D3

Q34983851-5068107D-7405-4DD1-AA24-B9BEA2FBF8F6

Q34983851-57A2F5CC-8C4C-45E9-A630-12770D663CE8

Q34983851-59C52DF1-2830-4697-A9E9-130A23CD825F

Q34983851-67A6507E-9523-4F3D-91F7-2040158D8318

Q34983851-68029477-505B-40E4-999C-2DA0FFA4E1EF

P304

Q34983851-3F08BB88-E141-4F13-BA1A-654D7DED80B0

P31

Q34983851-BCE00D96-F5DD-4D68-887E-97FCB7BF218F

P356

Q34983851-C79C3E5A-7DAE-4BD7-A701-DB2BF10B9758

P433

Q34983851-121DE6CF-6AA6-42EE-A389-C8D16D34578F

P478

Q34983851-26D38CC3-260B-41B3-B273-C9CDEE31981D

P577

Q34983851-BF5357CC-7FD9-438D-9965-5F72BCBE8D24

P5875

Q34983851-F9F39ADB-2EA6-43A9-9A01-613B0A6B39BF

P698

Q34983851-520de90a-a956-45d2-b987-bc55adcaa347

Q34983851-73137381-3EC4-4622-8587-E3FD9C8F40A5

P932

Q34983851-987F949D-1F04-4E53-B718-07C085CF228F

P356

P1433

Lymphatic Research and Biology

P1476

HGF and MET mutations in primary and secondary lymphedema

@en

P2093

Catherine J Baty

http://www.w3.org/2001/XMLSchema#string

David N Finegold

http://www.w3.org/2001/XMLSchema#string

Elizabeth C Lawrence

http://www.w3.org/2001/XMLSchema#string

Etelka Foeldi

http://www.w3.org/2001/XMLSchema#string

Jenny M Karlsson

http://www.w3.org/2001/XMLSchema#string

Mark A Kimak

http://www.w3.org/2001/XMLSchema#string

Robert E Ferrell

http://www.w3.org/2001/XMLSchema#string

Vivien Schacht

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor

Molecular cloning and expression of human hepatocyte growth factor

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region

c-Met: structure, functions and potential for therapeutic inhibition

A model for gene therapy of human hereditary lymphedema

Scatter factor/hepatocyte growth factor is essential for liver development

Molecular regulation of angiogenesis and lymphangiogenesis

The met proto-oncogene receptor and lumen formation.

Hepatocyte growth factor promotes lymphatic vessel formation and function.

P304

65-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/LRB.2008.1024

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23674777

http://www.w3.org/2001/XMLSchema#string

P698

18564920

http://www.w3.org/2001/XMLSchema#string

P932

4298750

http://www.w3.org/2001/XMLSchema#string